Citizens Upgrades LeonaBio to Market Outperform, Announces $18 Price Target
LeonaBio, Inc.
LeonaBio, Inc. LONA | 0.00 |
Citizens analyst Jason N. Butler upgrades LeonaBio (NASDAQ:
LONA) from Market Perform to Market Outperform and announces $18 price target.
